Title

Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.

Document Type

Journal Article

Publication Date

4-16-2019

Journal

Scientific Reports

Volume

9

Issue

1

Inclusive Pages

6136

DOI

10.1038/s41598-019-42237-3

Peer Reviewed

1

Open Access

1

Share

COinS